Back

G1 Therapeutics Quote, Financials, Valuation and Earnings

$50 trade to make today with huge potential!

Click here to access my #1 options strategy for overnight wins starting with $50!

Sell

GTHX
G1 Therapeutics

Last Price:

4.20

Seasonality Move:

23.56%

7 Day Trial

ALL ACCESS PASS

$ 7

My #1 Coin is...

All the details are on the next page.

G1 Therapeutics Price Quote

$4.20

+0.04 (+0.96%)

(Updated: April 19, 2024 at 10:35 AM ET)

G1 Therapeutics Key Stats

Sell

G1 Therapeutics (GTHX) is a Sell

Day range:

$4.04 - $4.31

52-week range:

$1.08 - $5.00

Dividend yield:

P/E ratio:

0.00

P/S ratio:

2.73

P/B ratio:

6.14%

Volume:

661.5K

Avg. volume:

799.2K

1-year change:

48.57%

Market cap:

$217.1M

Revenue:

$82.5M

EPS:

$-0.95

How Much Does G1 Therapeutics Make?

How Much Are G1 Therapeutics's Sales Annually?
GTHX Revenues are $82.5M
How Much Profit Does G1 Therapeutics's Make A Year?
GTHX net income is -$48M

Is G1 Therapeutics Growing As A Company?

What Is G1 Therapeutics's Growth Rate Quarterly?
Quarterly YoY revenue growth is 0.45%
What Is G1 Therapeutics's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is 0%

G1 Therapeutics Stock Price Performance

Did G1 Therapeutics Stock Go Up Last Month?
G1 Therapeutics share price went up by 29.6% last month
Did GTHX's Share Price Rise Over The Last Year?
GTHX share price rose by 48.57% over the past 1 year

What Is G1 Therapeutics 52-Week High & Low?

What Is G1 Therapeutics’s 52-Week High Share Price?
G1 Therapeutics has traded as high as $5.00 over the past 52 weeks
What Is G1 Therapeutics’s 52-Week Low Share Price?
G1 Therapeutics has traded as low as $1.08 over the past 52 weeks

G1 Therapeutics Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy G1 Therapeutics?

How Much Debt Does G1 Therapeutics Have?
Total long term debt quarterly is $51.6M
How Much Cash Does G1 Therapeutics Have?
Cash and short term investments quarterly total is $82.2M
What Is G1 Therapeutics’s Book Value Per Share?
Book value per share is 0.68

Is G1 Therapeutics Cash Flow Positive?

What Is GTHX Cash Flow From Operations?
Cash flow from operations (TTM) is -$38.3M
What Is G1 Therapeutics’s Cash Flow From Financing?
Cash flow from financing (TTM) is -$26.9M
What Is G1 Therapeutics’s Cash Flow From Investing?
Cash flow from investing (TTM) is $2.8M

G1 Therapeutics Return On Invested Capital

Is Management Doing A Good Job?
GTHX return on invested capital is -42.99%
What Is G1 Therapeutics Return On Assets?
ROA measures how assets are converting to revenues and is -31.87%
What Is GTHX Return On Equity?
ROE is a measure of profitability and is -96.05%

G1 Therapeutics Earnings Date & Stock Price

What Is G1 Therapeutics's Stock Price Today?
A single share of GTHX can be purchased today for 4.16
What Is G1 Therapeutics’s Stock Symbol?
G1 Therapeutics trades on the nasdaq under the ticker symbol: GTHX
When Is G1 Therapeutics’s Next Earnings Date?
The next quarterly earnings date for G1 Therapeutics is scheduled on May 1, 2024
When Is GTHX's next ex-dividend date?
G1 Therapeutics's next ex-dividend date is May 20, 2020
How To Buy G1 Therapeutics Stock?
You can buy G1 Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

G1 Therapeutics Competitors

Who Are G1 Therapeutics's Competitors?
Below is a list of companies who compete with G1 Therapeutics or are related in some way:
- Amicus Therapeutics Inc (FOLD)
- Geron Corp (GERN)
- Oragenics Inc (OGEN)
- Palatin Technologies Inc (PTN)
- TG Therapeutics Inc (TGTX)

G1 Therapeutics Dividend Yield